AAAAAA
Results:
1-12
|
Results: 12
Authors:
GORE SD
ROWINSKY EK
MILLER CB
GRIFFIN C
CHEN TL
BOROWITZ M
DONEHOWER RC
BURKS KL
ARMSTRONG DK
BURKE PJ
GREVER MR
KAUFMANN SH
Citation: Sd. Gore et al., A PHASE-II WINDOW STUDY OF TOPOTECAN IN UNTREATED PATIENTS WITH HIGH-RISK ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Clinical cancer research, 4(11), 1998, pp. 2677-2689
Authors:
JOY MS
MATZKE GR
ARMSTRONG DK
MARX MA
ZAROWITZ BJ
Citation: Ms. Joy et al., A PRIMER ON CONTINUOUS RENAL REPLACEMENT THERAPY FOR CRITICALLY ILL PATIENTS, The Annals of pharmacotherapy, 32(3), 1998, pp. 362-375
Authors:
OREILLY S
FLEMING GF
BAKER SD
WALCZAK JR
BOOKMAN MA
MCGUIRE WP
SCHILDER RJ
ALVAREZ RD
ARMSTRONG DK
HOROWITZ IR
OZOLS RF
ROWINSKY EK
Citation: S. Oreilly et al., PHASE-I TRIAL AND PHARMACOLOGICAL TRIAL OF SEQUENCES OF PACLITAXEL AND TOPOTECAN IN PREVIOUSLY TREATED OVARIAN EPITHELIAL MALIGNANCIES - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(1), 1997, pp. 177-186
Authors:
OREILLY S
ARMSTRONG DK
GROCHOW LB
Citation: S. Oreilly et al., LIFE-THREATENING MYELOSUPPRESSION IN PATIENTS WITH OCCULT RENAL IMPAIRMENT RECEIVING TOPOTECAN, Gynecologic oncology, 67(3), 1997, pp. 329-330
Authors:
KAUFMANN SH
SVINGEN PA
GORE SD
ARMSTRONG DK
CHENG YC
ROWINSKY EK
Citation: Sh. Kaufmann et al., ALTERED FORMATION OF TOPOTECAN-STABILIZED TOPOISOMERASE-I DNA-ADDUCTSIN HUMAN LEUKEMIA-CELLS, Blood, 89(6), 1997, pp. 2098-2104
Authors:
KENNEDY MJ
ARMSTRONG DK
HUELSKAMP AM
OHLY K
CLARKE BV
COLVIN OM
GROCHOW LB
CHEN TL
DAVIDSON NE
Citation: Mj. Kennedy et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE ALKYLATING AGENT MODULATOR NOVOBIOCIN IN COMBINATION WITH HIGH-DOSE CHEMOTHERAPY FOR THE TREATMENTOF METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(5), 1995, pp. 1136-1143
Authors:
MAY WS
TYLER PG
ITO T
ARMSTRONG DK
QATSHA KA
DAVIDSON NE
Citation: Ws. May et al., INTERLEUKIN-3 AND BRYOSTATIN-1 MEDIATE HYPERPHOSPHORYLATION OF BCL2-ALPHA IN ASSOCIATION WITH SUPPRESSION OF APOPTOSIS, The Journal of biological chemistry, 269(43), 1994, pp. 26865-26870
Authors:
ARMSTRONG DK
KAUFMANN SH
OTTAVIANO YL
FURUYA Y
BUCKLEY JA
ISAACS JT
DAVIDSON NE
Citation: Dk. Armstrong et al., EPIDERMAL GROWTH FACTOR-MEDIATED APOPTOSIS OF MDA-MB-468 HUMAN BREAST-CANCER CELLS, Cancer research, 54(20), 1994, pp. 5280-5283
Authors:
ARMSTRONG DK
Citation: Dk. Armstrong, COMMENT - VANCOMYCIN AND TOBRAMYCIN CONTINUOUS HEMOFILTRATION CLEARANCE METHODOLOGIES - REPLY, The Annals of pharmacotherapy, 27(10), 1993, pp. 1286-1286
Authors:
MAY WS
TYLER PG
ARMSTRONG DK
DAVIDSON NE
Citation: Ws. May et al., REGULATION OF BCL2 AND APOPTOSIS BY IL-3 AND EPO, Experimental hematology, 21(8), 1993, pp. 1029-1029
Authors:
ARMSTRONG DK
FETTING JH
DAVIDSON NE
GORDON GB
HUELSKAMP AM
ABELOFF MD
Citation: Dk. Armstrong et al., 16 WEEK DOSE INTENSE CHEMOTHERAPY FOR INOPERABLE, LOCALLY ADVANCED BREAST-CANCER, Breast cancer research and treatment, 28(3), 1993, pp. 277-284
Authors:
MAY WS
TYLER PG
ARMSTRONG DK
DAVIDSON NE
Citation: Ws. May et al., ROLE FOR SERINE PHOSPHORYLATION OF BCL2 IN AN ANTIAPOPTOTIC SIGNALINGPATHWAY TRIGGERED BY IL-3, EPO AND BRYOSTATIN, Blood, 82(10), 1993, pp. 10000438-10000438
Risultati:
1-12
|